2-((3-Ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)-N-mesitylacetamide

Catalog No. :
ACYGTW816
CAS No. :
577960-87-3
Molecular Formula :
C23H27N3O2S2
Molecular Weight :
441.62

IUPAC Name:2-((3-ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)-N-mesitylacetamide

2-((3-Ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)-N-mesitylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((3-Ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)-N-mesitylacetamide
IUPAC Name2-((3-ethyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)-N-mesitylacetamide
MDL No.MFCD04028577
Molecular FormulaC23H27N3O2S2
Molecular Weight441.62
SMILESO=C(NC1=C(C)C=C(C)C=C1C)CSC2=NC3=C(C4=C(CCCC4)S3)C(N2CC)=O
InChI KeySRDGDVCALKABHQ-UHFFFAOYSA-N
SynonymSALOR-INT L413682-1EA;2-[(3-ETHYL-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]-N-MESITYLACETAMIDE;Acetamide, 2-[(3-ethyl-3,4,5,6,7,8-hexahydro-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl)thio]-N-(2,4,6-trimethylphenyl)-
CAS No.577960-87-3

Synthetic Route by SureRoute

1. ACYGTW816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYGTW816 route product structure diagram
    ACYGTW816577960-87-3
Inquiry

2. ACYGTW816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCSAJ401 route compound structure diagram
    ACCSAJ4013910-51-8 In Stock
  4. Then
  5. ACYGTW816 route product structure diagram
    ACYGTW816577960-87-3
Inquiry

Comments (0)